Eisai Co. of Japan will advance into clinical trials with a promising candidate cancer vaccine. The vaccine has no major side effects so far in a small-scale trial on roughly 40 cancer patients in the…
READ MORE
Eisai Co. of Japan will advance into clinical trials with a promising candidate cancer vaccine. The vaccine has no major side effects so far in a small-scale trial on roughly 40 cancer patients in the…
READ MORE